Financials Seyitler Kimya Sanayi

Equities

SEYKM

TRESEYT00011

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Istanbul 16:09:59 17/05/2024 BST 5-day change 1st Jan Change
9.4 TRY +2.51% Intraday chart for Seyitler Kimya Sanayi +2.17% +65.20%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 61.6 108.6 552 410.8 676.1 569
Enterprise Value (EV) 1 60.79 103.2 536.9 377.9 613.1 524.4
P/E ratio 23.4 x 22.6 x 27.3 x 30.4 x 9.47 x -
Yield - - - - - -
Capitalization / Revenue 2.57 x 3.29 x 10.4 x 6.82 x 6.09 x 2.9 x
EV / Revenue 2.53 x 3.12 x 10.1 x 6.28 x 5.52 x 2.68 x
EV / EBITDA 17.3 x 21.6 x 54.4 x 37.7 x 20 x 39.1 x
EV / FCF -105 x 107 x -68.5 x -241 x -21 x -8.81 x
FCF Yield -0.95% 0.94% -1.46% -0.41% -4.77% -11.3%
Price to Book 2.7 x 3.93 x 11.5 x 5.69 x 4.71 x -
Nbr of stocks (in thousands) 100,001 100,000 100,000 100,000 100,000 100,000
Reference price 2 0.6160 1.086 5.520 4.108 6.761 5.690
Announcement Date 28/02/19 20/02/20 23/02/21 28/02/22 24/02/23 08/05/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 24.01 33.04 52.9 60.19 111 196.1
EBITDA 1 3.505 4.785 9.871 10.03 30.6 13.41
EBIT 1 2.628 3.987 8.757 8.399 28.62 4.261
Operating Margin 10.94% 12.07% 16.55% 13.95% 25.78% 2.17%
Earnings before Tax (EBT) 1 3.388 5.652 20.25 24.53 79.35 -70.2
Net income 1 2.63 4.805 20.2 24.34 71.43 -69.81
Net margin 10.95% 14.54% 38.18% 40.43% 64.36% -35.61%
EPS 2 0.0263 0.0480 0.2020 0.1353 0.7143 -
Free Cash Flow 1 -0.577 0.9688 -7.833 -1.567 -29.26 -59.5
FCF margin -2.4% 2.93% -14.81% -2.6% -26.36% -30.35%
FCF Conversion (EBITDA) - 20.25% - - - -
FCF Conversion (Net income) - 20.16% - - - -
Dividend per Share - - - - - -
Announcement Date 28/02/19 20/02/20 23/02/21 28/02/22 24/02/23 08/05/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.81 5.46 15.1 32.9 63 44.6
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.58 0.97 -7.83 -1.57 -29.3 -59.5
ROE (net income / shareholders' equity) 12.2% 19% 53.5% 40.5% 66.2% -37.4%
ROA (Net income/ Total Assets) 6.71% 7.87% 10% 6.3% 12.2% 1.11%
Assets 1 39.21 61.05 201.1 386.3 586.7 -6,273
Book Value Per Share 2 0.2300 0.2800 0.4800 0.7200 1.440 -
Cash Flow per Share 2 0.0100 0.0200 0.0500 0.1800 0.3300 -
Capex 1 0.48 1.89 5.62 5.41 2.87 31.5
Capex / Sales 2% 5.72% 10.62% 8.99% 2.59% 16.05%
Announcement Date 28/02/19 20/02/20 23/02/21 28/02/22 24/02/23 08/05/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SEYKM Stock
  4. Financials Seyitler Kimya Sanayi